1. Wang, Shuo, Chen, Jiang, Guo, Xiao-Zhong. . KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers. In World journal of gastrointestinal oncology, 14, 1388-1405. doi:10.4251/wjgo.v14.i8.1388. https://pubmed.ncbi.nlm.nih.gov/36160748/
2. Prabhu, Venugopal Vinod, Devaraj, S Niranjali. . KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma. In Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 36, 269-275. doi:10.1615/JEnvironPatholToxicolOncol.2017024619. https://pubmed.ncbi.nlm.nih.gov/29283339/
3. Al-Khater, Khulood M, Almofty, Sarah, Ravinayagam, Vijaya, Alrushaid, Noor, Rehman, Suriya. 2021. Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer. In Saudi journal of biological sciences, 28, 3391-3398. doi:10.1016/j.sjbs.2021.03.001. https://pubmed.ncbi.nlm.nih.gov/34121877/
4. Tonoli, Hélène, Barrett, J Carl. 2005. CD82 metastasis suppressor gene: a potential target for new therapeutics? In Trends in molecular medicine, 11, 563-70. doi:. https://pubmed.ncbi.nlm.nih.gov/16271511/
5. Li, Ming-Qing, Hou, Xiao-Fan, Lv, Shi-Jian, Tang, Chuan-Ling, Li, Da-Jin. 2011. CD82 gene suppression in endometrial stromal cells leads to increase of the cell invasiveness in the endometriotic milieu. In Journal of molecular endocrinology, 47, 195-208. doi:10.1530/JME-10-0165. https://pubmed.ncbi.nlm.nih.gov/21685244/
智鼠故事 
